Navigation Links
Angiotensin-II-receptor blockers - Treat kidney failure

Drugs used to treat high blood pressure have been found to also help slow the progress of kidney failure. Three separate drug trials reveal that the angiotensin-II-receptor blockers, which include losartan and irbesartan, can be used to treat kidney failure, one of the commonest complications in diabetes. //

In the first trial, carried out by doctors in Boston, USA, 1500 patients with type 2 diabetes and kidney disease were given either losartan or placebo. After three years of follow up, the losartan group had a 28 per cent lower risk of end-stage kidney disease. This is equivalent to delaying the need for dialysis or transplantation by two years.

The second trial involved researchers in Chicago who found that the progression of kidney disease or death was reduced by around 20 per cent in patients on irbesartan. Even those with advanced disease could benefit, although the treatment is best started early on. A final study of irbesartan on diabetic patients with early signs of kidney disease showed the condition was less likely to progress than in similar patients on placebo. The trials offer new hope to people with diabetes, for there has been no treatment for kidney complications till now. They also underline the need for the earliest possible diagnosis of kidney disease in people with diabetes.


'"/>




Page: 1

Related medicine news :

1. Calcium-blocker delays atherosclerosis than beta-blockers
2. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
3. Alpha-blockers call for modification in cataract surgery
4. Advances in Treatment of Cataracts
5. Recommendations for Treatment of Blood Pressue
6. New FDA Approved Drug To Treat Migraine
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Cipro Has Cheaper Cousins to Treat Anthrax
10. Better Treatment for obesity
11. Gene Treatment for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: